Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Cellulite Cream

Racial Disparities In Colorectal Cancer Survival Dissipate After Adjusting For Other Demographic And Clinical Factors
Colorectal cancer (CRC) is the third leading cause of cancer death in both men and women and the second leading cause of cancer death when both sexes are combined. African Americans have lower survival rates compared to whites. Researchers at Barbara Ann Karmanos Cancer Institute, in Detroit, Michigan in Detroit sought to investigate the effect of demographics, clinical factors and socioeconomic status (SES) on racial disparities in CRC survival in the Detroit Metropolitan Area.
generic viagra online
Cook Medical Introduces The Guardia™ Pro Protective Embryo Transfer Catheter
The Guardia Pro Protective Embryo Transfer Catheteris uniquely engineered to protect and guide embryos through cervical mucus and blood and to eliminate the need for cervical flushing or aspiration prior to transfer.
News of the day
Arena Pharmaceuticals Announces The Presentation Of Lorcaserin Phase 3 BLOOM Data At The American Diabetes Association's 69th Scientific Sessions
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that a late-breaking abstract of its lorcaserin Phase 3 BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial has been accepted for a poster presentation at the American Diabetes Association"s 69th Scientific Sessions in New Orleans, Louisiana. The abstract, titled "Lorcaserin Reduces Body Weight in Obese and Overweight Subjects: Behavioral Modification and Lorcaserin for Overweight and Obesity Management, the BLOOM Trial," will be displayed from June 6, 2009 at 10:00 a.m. Central Daylight Time (CDT) until June 8, 2009 at 4:00 p.m. CDT in the Morial Convention Center, Hall E. The poster has been assigned presentation number 96-LB in category 20-B Obesity - Clinical Treatment.
Mental Health

Sotomayor Nomination Lacks Controversy GOP Had Hoped To Generate

Supreme Court nominee Judge Sonia Sotomayor has not become the "political lightning rod" Republican senators hoped for, leaving doubt among some members of the GOP that the nomination process will be controversial enough to help them or hurt Democrats in the 2010 elections, Politico reports. Sen. John Thune (R-S.D.) said that "at least so far" Sotomayor "doesn"t have the punch put there in terms of fundraising and recruiting." Thune said that one reason the GOP response to Sotomayor has been relatively quiet is that she is nominated to replace retiring Justice David Souter, rather than a more conservative justice. "When one of the conservatives leaves the court, then I think you"ll have a huge fight, and I think that will be very galvanizing," Thune said. Similarly, Sen. John Cornyn (R-Texas), a member of the Senate Judiciary Committee and chair of the National Republican Senatorial Committee, said he does not foresee Sotomayor"s nomination becoming a major issue in the 2010 campaigns. Sen. Jeff Sessions (R-Ala.), the ranking Republican on the Judiciary Committee, said that the GOP would use witnesses at Sotomayor"s confirmation hearing to present some opposition arguments (Raju, Politico, 6/22). Sessions and other Senate Republicans are preparing a series of speeches to highlight their concerns about Sotomayor, the Wall Street Journal reports. According to a Senate Republican aide, the focus of Sessions" speech will be Sotomayor"s role in the group LatinoJustice PRLDEF, for which she served as a board member from 1980 to 1992. Unless new information surfaces, there are few doubts that Sotomayor will be confirmed, the Journal reports (Bravin, Wall Street Journal, 6/22). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009